Koumans and team pointed out that while adults ages 65 and older make up 17.7% of the U.S. population, this group bore a ...

Let’s be clear. The primary reason to be vaccinated against shingles is that two shots provide 90 percent protection against a painful, blistering disease that a third of Americans will suffer in ...

The Union Ministry of Health and Family Welfare has launched the ‘World Health Organization (WHO) India Country Cooperation Strategy 2019-2023: A Time of Transition programme in New Delhi.<br /><br /> ...

CHARLESTON, S.C. (WCIV) — Flu activity is climbing rapidly across South Carolina, with health officials reporting doctor visits for flu-like illness now well above the state’s normal baseline.

If licensed and in the event of an influenza pandemic, Moderna will allocate 20% of its H5 pandemic vaccine manufacturing capacity for timely supply to low- and middle-income countries at affordable ...

Everyone's home for the holidays — and so are the germs. It's possible sickness could be knocking on the door along with your party guests. It's cold and flu season, and common winter illnesses such ...

(The Hill) — Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover ...

The super flu strain is spreading widely around the country. The nation’s hospitalization rate went up by 14.3 % as of Friday, according to the Centers for Disease Control and Prevention. Public ...

Moderna’s earnings and stock price climbed during early pandemic days -- that’s as demand for the company’s coronavirus vaccine soared. Since, the company has faced various challenges that have ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups could help fill the void after the Trump administration slashed federal ...

Dec 18 (Reuters) - Moderna (MRNA.O), opens new tab will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S.